Wang J - Search Results

1

LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.

Wang Z, Yu Y, Ma J, Zhang H, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Wang Z, et al. Among authors: wang x, wang j. Mol Pharm. 2012 Sep 4;9(9):2646-57. doi: 10.1021/mp3002107. Epub 2012 Aug 13. Mol Pharm. 2012. PMID: 22853186

2

In vitro cytotoxicity of Stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells.

Wang J, Goh B, Lu W, Zhang Q, Chang A, Liu XY, Tan TM, Lee H. Wang J, et al. Biol Pharm Bull. 2005 May;28(5):822-8. doi: 10.1248/bpb.28.822. Biol Pharm Bull. 2005. PMID: 15863886 Free article.

3

Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats.

Wang JC, Liu XY, Lu WL, Chang A, Zhang Q, Goh BC, Lee HS. Wang JC, et al. Eur J Pharm Biopharm. 2006 Jan;62(1):44-51. doi: 10.1016/j.ejpb.2005.06.004. Epub 2005 Aug 29. Eur J Pharm Biopharm. 2006. PMID: 16126379

4

[The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].

Wang JC, Liu XY, Lü WL, Lee HS, Goh BC, Zhang Q. Wang JC, et al. Yao Xue Xue Bao. 2005 May;40(5):475-80. Yao Xue Xue Bao. 2005. PMID: 16220797 Chinese.

5

Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers.

Wang J, Lu WL, Liang GW, Wu KC, Zhang CG, Zhang X, Wang JC, Zhang H, Wang XQ, Zhang Q. Wang J, et al. Among authors: wang jc, wang xq. Peptides. 2006 Apr;27(4):826-35. doi: 10.1016/j.peptides.2005.09.008. Epub 2005 Oct 19. Peptides. 2006. PMID: 16242213 Free PMC article.

6

A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia.

Li X, Ruan GR, Lu WL, Hong HY, Liang GW, Zhang YT, Liu Y, Long C, Ma X, Yuan L, Wang JC, Zhang X, Zhang Q. Li X, et al. J Control Release. 2006 May 15;112(2):186-98. doi: 10.1016/j.jconrel.2006.01.007. Epub 2006 Mar 3. J Control Release. 2006. PMID: 16516327

7

Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.

He Y, Wang JC, Liu YL, Ma ZZ, Zhu XA, Zhang Q. He Y, et al. J Ocul Pharmacol Ther. 2006 Apr;22(2):121-31. doi: 10.1089/jop.2006.22.121. J Ocul Pharmacol Ther. 2006. PMID: 16722798

8

Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.

Wang XQ, Huang J, Dai JD, Zhang T, Lü WL, Zhang H, Zhang X, Wang JC, Zhang Q. Wang XQ, et al. Among authors: wang jc. Int J Pharm. 2006 Sep 28;322(1-2):146-53. doi: 10.1016/j.ijpharm.2006.05.021. Epub 2006 May 16. Int J Pharm. 2006. PMID: 16787721

9

Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.

He Y, Liu Y, Liu Y, Wang J, Zhang X, Lu W, Ma Z, Zhu X, Zhang Q. He Y, et al. Among authors: wang j. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3983-8. doi: 10.1167/iovs.05-1373. Invest Ophthalmol Vis Sci. 2006. PMID: 16936114

10

Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer.

Li MG, Lu WL, Wang JC, Zhang X, Zhang H, Wang XQ, Wu CS, Zhang Q. Li MG, et al. J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2874-86. doi: 10.1166/jnn.2006.411. J Nanosci Nanotechnol. 2006. PMID: 17048494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219,999 results

Search Page

Filters